Market Cap: $116.25M
NI
NRx Pharmaceuticals, Inc.
NRXP
NASDAQ (NASDAQ Global Market)USD
Market Cap: $116.25M
Shifting Perspectives: Ketamine's Promising Role in Mental Health Treatment Ketamine, traditionally known for its use as an anesthetic, is experiencing a significant transformation in its application…
Shifting Paradigms: Ketamine's Role in Mental Health Treatment NRX Pharmaceuticals stands at the forefront of a growing movement that highlights ketamine's transformative potential in mental health tr…
NRX Pharmaceuticals: Navigating Challenges in the Biopharmaceutical Landscape NRX Pharmaceuticals is currently focusing on advancing its innovative therapeutic solutions, particularly in the context o…
NRX Pharmaceuticals: Focus on Innovation and Market Strategy Amid Competitive Landscape NRX Pharmaceuticals, a player in the biopharmaceutical sector, continues to navigate the complexities of drug de…
NRX Pharmaceuticals Prepares for Key Quarterly Earnings Report NRX Pharmaceuticals is gearing up to announce its quarterly earnings on November 17, 2025, a pivotal moment for the company as it seeks t…
NRX Pharmaceuticals Gears Up for Earnings Announcement: A Focus on Innovation and Strategic Direction As NRX Pharmaceuticals approaches its quarterly earnings announcement on November 17, 2025, the sp…
NRX Pharmaceuticals Prepares for Key Earnings Announcement Amidst Strategic Developments NRX Pharmaceuticals gears up for its quarterly earnings announcement on November 17, 2025, a moment that promis…
NRX Pharmaceuticals Poised for Key Earnings Announcement Amidst Strategic Developments NRX Pharmaceuticals (NRXP) gears up to unveil its quarterly earnings report on August 14, 2025, a moment that hol…
NRX Pharmaceuticals Receives Fast Track Designation for NRX-100: A Game Changer in Suicide Prevention NRX Pharmaceuticals, Inc. announces a significant milestone in its quest to address the urgent iss…
NRX Pharmaceuticals Secures Fast Track Designation for Innovative Suicidal Ideation Treatment NRX Pharmaceuticals, Inc. announces a significant advancement in its clinical development efforts with the…
NRx Pharmaceuticals Expands Mental Health Services Through Dura Medical Acquisition NRx Pharmaceuticals, Inc. solidifies its commitment to enhancing mental health services with the recent acquisition…
HOPE Therapeutics Strengthens Mental Health Services with Dura Medical Acquisition In a significant advancement for mental health care in Florida, HOPE Therapeutics, Inc., a subsidiary of NRx Pharmace…
HOPE Therapeutics Expands Mental Health Services through Dura Medical Acquisition In a significant stride towards bolstering mental health services in Florida, HOPE Therapeutics, Inc., a subsidiary of…
NRx Pharmaceuticals Seeks Fast-Track Approval for Groundbreaking Ketamine Treatment NRx Pharmaceuticals, Inc. is at the forefront of an important development in the biopharmaceutical industry as it su…